Publications by authors named "Shashank R Gupta"
Purpose: To evaluate the anatomic and visual outcomes and safety profile of initial Indian eyes with neovascular age-related macular degeneration (nAMD) treated with intravitreal injection (IVI) of brolucizumab.
Methods: This retrospective multicentric, real-world study enrolled consecutive eyes with nAMD that were treated with IVI brolucizumab after it was launched in India in October 2020. Data collected for each eye included best-corrected visual acuity (BCVA), central subfield thickness (CSFT), subretinal fluid (SRF), and intraretinal fluid (IRF) status at 6, 12, and 24 months follow-up.
Purpose: The aim of this study was to present the outcomes of the 2018 and 2020 Vitreo-retinal Society of India (VRSI) biosimilars of anti-vascular endothelial growth factor (VEGF) (VIBE) surveys.
Methods: An online survey of members of VRSI was conducted in July 2018 and January 2020 regarding their practice-patterns on anti-VEGF biosimilars pertaining to safety, efficacy, pricing, and need for enhanced clinical trials before regulatory approval.
Results: In 2018, 112 VRSI members participated, whereas in 2020, 98 society members participated.
Salvaging recurrent scleral buckle exposure with autologous periosteal patch graft.
Retin Cases Brief Rep
June 2015
Purpose: To describe a surgical technique for salvaging recurrent exposure of scleral buckle.
Methods: A patient, treated for rhegmatogenous retinal detachment with scleral buckle, presented with exposed uninfected buckle 3 weeks after the initial surgery. We tried to cover the exposure twice with conjunctivoplasty and once with scleral patch graft with amniotic membrane transplantation, but each one of them failed.
Purpose: We report iatrogenic occurrence of a macular tractional retinal detachment with macular hole in nonperfused hemiretinal vein occlusion and describe its management with vitrectomy, without internal limiting membrane peeling.
Methods: A 40-year-old man with diabetes was treated with scatter photocoagulation for a unilateral nonperfused hemiretinal vein occlusion with a florid neovascularization at optic disk and best-corrected visual acuity of 20/200. A month later, he developed an extensive tractional detachment of the posterior pole with a macular hole, with further drop in vision to hand motions.
Purpose: To describe the natural course of Type 2 idiopathic macular telangiectasia in terms of visual outcomes, causes of visual loss, and incidence of subretinal neovascular membranes (SRNV).
Methods: This retrospective observational case series consisted of chart review of 104 outpatients (203 eyes; 66 women, 38 men) who were diagnosed to have Type 2 idiopathic macular telangiectasia by clinical examination and fluorescein angiography between January 2000 and December 2008. Visual and anatomic outcomes were analyzed during a minimum follow-up of 1 year.